首页 › 股票 › KYMR

KYMR — KYMERA THERAPEUTICS INC

申报持仓市值$13.00B
持有基金数(最新)477
板块医疗保健

什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么

持有机构数 (Q2 2026)294
机构持仓市值$11.73B · 109.68M 股
新建/增持/减仓/清仓55 / 101 / 84 / 29 · 更新于 2026-11-14
前五大/前十大集中度40.9% / 60.2%
机构整体持仓变动 减持 -0.1% (-107.16K 股)
机构持仓市值变动 上升 +35.8%

最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR

截至Q2 2026,共 294 家机构在其最新 13F 申报中持有 KYMR(KYMERA THERAPEUTICS INC),合计申报市值 $11.73B,对应 109.68M 股。按股数计算较上季度减持 0.1%(-107.16K 股),申报市值环比上升 35.8%。持仓集中度较高:前五大持有人占申报市值的 40.9%,前十大的集中度为 60.2%。

与上一季度相比,55 家新建仓位、101 家加仓、84 家减仓、29 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。

KYMERA THERAPEUTICS INC(KYMR)的主要机构持有人包括 Fidelity Management & Research (FMR)、BAKER BROS. ADVISORS LP、Avoro Capital Advisors LLC,按 13F 申报市值在本页 477 家持有人中排名居前。

KYMR 属于Health Care板块。

本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。

机构逐季持仓趋势

季度 持有机构数 股数 金额 环比净变动
Q3 2026 217 47.25M $5.30B +2.1%
Q2 2026 294 109.68M $11.73B +0.6%
Q1 2026 266 108.40M $8.52B +7.0%
Q4 2025 264 102.39M $7.49B +9.1%
Q3 2025 214 92.80M $4.96B +0.0%
Q2 2025 213 92.13M $3.72B +2.3%
Q1 2025 176 86.76M $2.19B +3.0%
Q4 2024 181 84.92M $3.10B +3.4%

表内 8 个季度中,机构持股合计减少 44%(Q4 2024 → Q3 2026);单季变动最大的是 Q4 2025(+9.1%)。

前 25 大机构持仓人(Q3 2026) — 25 家基金

基金股数金额组合权重变化
Fidelity Management & Research (FMR) 12.57M $1.41B 0.06% 增持
BlackRock Inc 5.83M $651.22M 0.01% 增持
VANGUARD CAPITAL MANAGEMENT LLC 3.04M $340.31M 0.01% 增持
VANGUARD PORTFOLIO MANAGEMENT LLC 2.98M $332.97M 0.01% 持有
Atlas Venture Life Science Advisors, LLC 历史持仓 2.85M $318.33M 50.43% 持有
Siren, L.L.C. 历史持仓 2.78M $311.32M 7.39% 减持
STATE STREET CORP 2.58M $288.75M 0.01% 增持
Geode Capital Management 1.91M $213.96M 0.01% 增持
Capital Research Global Investors 1.13M $126.36M 0.02% 减持
UBS Group AG 1.03M $115.64M 0.05% 增持
Merck & Co., Inc. 历史持仓 772.16K $86.32M 10.52% 持有
FEDERATED HERMES, INC. 747.43K $83.56M 0.12% 持有
DIMENSIONAL FUND ADVISORS LP 693.29K $77.50M 0.01% 减持
Franklin Resources 552.28K $75.25M 0.02% 增持
VANGUARD FIDUCIARY TRUST CO 503.09K $56.24M 0.01% 增持
EVENTIDE ASSET MANAGEMENT, LLC 历史持仓 490.61K $54.84M 0.77% 减持
Clearbridge Investments, LLC 396.83K $44.36M 0.04% 增持
BNP PARIBAS FINANCIAL MARKETS 382.80K $42.79M 0.07% 增持
Morgan Stanley 359.19K $40.15M 0.00% 增持
Fisher Asset Management, LLC 323.22K $36.13M 0.01% 增持
Pictet Asset Management Holding SA 298.93K $33.36M 0.04% 减持
LORD, ABBETT & CO. LLC 246.78K $27.59M 0.09% 新进
Connor, Clark & Lunn Investment Management Ltd. 233.52K $26.11M 0.05% 增持
TD ASSET MANAGEMENT INC 227.18K $25.11M 0.02% 减持
BNY Mellon 223.81K $25.02M 0.01% 增持

↑ 返回持仓列表顶部

更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人

Q2 2026 — 25 家基金

基金股数金额组合权重变化
Fidelity Management & Research (FMR) 12.35M $1.42B 0.06% 增持
BAKER BROS. ADVISORS LP 历史持仓 8.66M $992.73M 5.19% 持有
Avoro Capital Advisors LLC 历史持仓 7.47M $857.13M 7.70% 持有
PRICE T ROWE ASSOCIATES INC /MD/ 7.11M $815.65M 0.08% 增持
T. Rowe Price Investment Management, Inc. 历史持仓 6.26M $717.52M 0.47% 增持
BlackRock Inc 5.54M $635.07M 0.01% 增持
BVF INC/IL 历史持仓 3.87M $444.01M 11.35% 减持
Wellington Management Group 3.68M $421.42M 0.08% 减持
WELLINGTON MANAGEMENT GROUP LLP 3.68M $421.42M 0.08% 减持
VANGUARD PORTFOLIO MANAGEMENT LLC 2.99M $343.11M 0.01% 增持
Siren, L.L.C. 历史持仓 2.94M $336.65M 6.83% 减持
VANGUARD CAPITAL MANAGEMENT LLC 2.93M $336.26M 0.01% 增持
Atlas Venture Life Science Advisors, LLC 历史持仓 2.85M $326.53M 37.05% 减持
GEODE CAPITAL MANAGEMENT, LLC 1.82M $208.32M 0.01% 新进
Geode Capital Management 1.82M $208.32M 0.01% 增持
Capital Research Global Investors 1.39M $159.26M 0.02% 减持
Capital Research Global Investors 1.39M $159.26M 0.02% 减持
Goldman Sachs Group 1.19M $136.15M 0.04% 增持
UBS Group AG 1.01M $115.56M 0.05% 减持
DRIEHAUS CAPITAL MANAGEMENT LLC 历史持仓 919.23K $105.41M 0.61% 减持
Merck & Co., Inc. 历史持仓 772.16K $88.54M 16.82% 持有
Norges Bank Investment Management 757.25K $86.83M 0.01% 增持
FEDERATED HERMES, INC. 749.40K $85.93M 0.12% 增持
DIMENSIONAL FUND ADVISORS LP 745.15K $85.42M 0.01% 增持
FRONTIER CAPITAL MANAGEMENT CO LLC 历史持仓 740.87K $84.96M 0.79% 减持

Q1 2026 — 25 家基金

基金股数金额组合权重变化
Fidelity Management & Research (FMR) 11.70M $974.49M 0.05% 增持
BAKER BROS. ADVISORS LP 历史持仓 8.66M $721.06M 4.37% 持有
Avoro Capital Advisors LLC 历史持仓 7.47M $622.57M 7.57% 持有
PRICE T ROWE ASSOCIATES INC /MD/ 6.06M $504.81M 0.06% 减持
BVF INC/IL 历史持仓 5.50M $458.32M 14.60% 持有
T. Rowe Price Investment Management, Inc. 历史持仓 5.46M $455.18M 0.31% 增持
BlackRock Inc 5.06M $421.52M 0.01% 增持
Atlas Venture Life Science Advisors, LLC 历史持仓 4.58M $381.30M 48.26% 减持
Wellington Management Group 3.89M $323.97M 0.06% 减持
WELLINGTON MANAGEMENT GROUP LLP 3.89M $323.97M 0.07% 减持
Siren, L.L.C. 历史持仓 3.19M $265.43M 7.36% 减持
VANGUARD CAPITAL MANAGEMENT LLC 2.88M $239.90M 0.01% 新进
VANGUARD PORTFOLIO MANAGEMENT LLC 2.87M $239.38M 0.01% 新进
STATE STREET CORP 2.39M $199.04M 0.01% 增持
Capital Research Global Investors 1.67M $139.37M 0.02% 增持
Capital Research Global Investors 1.67M $139.37M 0.02% 增持
Geode Capital Management 1.65M $137.07M 0.01% 增持
DRIEHAUS CAPITAL MANAGEMENT LLC 历史持仓 1.04M $86.92M 0.64% 减持
UBS Group AG 1.02M $85.28M 0.04% 增持
Goldman Sachs Group 888.41K $74.00M 0.03% 增持
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME 875.87K $72.95M 0.01% 减持
Holocene Advisors, LP 836.76K $69.69M 0.17% 增持
ALLIANCEBERNSTEIN L.P. 888.03K $69.10M 0.02% 减持
Merck & Co., Inc. 历史持仓 772.16K $64.31M 18.41% 持有
FRONTIER CAPITAL MANAGEMENT CO LLC 历史持仓 759.85K $63.29M 0.65% 增持

Q4 2025 — 25 家基金

基金股数金额组合权重变化
Fidelity Management & Research (FMR) 8.93M $694.73M 0.04% 增持
BAKER BROS. ADVISORS LP 历史持仓 8.66M $673.62M 4.13% 增持
Avoro Capital Advisors LLC 历史持仓 7.47M $581.61M 6.40% 增持
Vanguard Group 6.27M $487.69M 0.01% 增持
PRICE T ROWE ASSOCIATES INC /MD/ 6.16M $479.26M 0.05% 增持
BVF INC/IL 历史持仓 5.50M $428.17M 14.41% 持有
BlackRock Inc 5.00M $389.37M 0.01% 增持
Atlas Venture Life Science Advisors, LLC 历史持仓 4.66M $362.58M 41.91% 减持
Wellington Management Group 4.41M $343.37M 0.06% 减持
WELLINGTON MANAGEMENT GROUP LLP 4.41M $343.37M 0.07% 减持
Siren, L.L.C. 历史持仓 3.29M $255.75M 7.63% 减持
STATE STREET CORP 2.21M $171.95M 0.01% 增持
Capital Research Global Investors 1.56M $121.45M 0.02% 增持
Capital Research Global Investors 1.56M $121.45M 0.02% 增持
Geode Capital Management 1.42M $110.31M 0.01% 增持
DRIEHAUS CAPITAL MANAGEMENT LLC 历史持仓 1.07M $83.20M 0.56% 增持
ALLIANCEBERNSTEIN L.P. 952.07K $74.08M 0.02% 增持
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME 912.50K $71.00M 0.01% 增持
Merck & Co., Inc. 历史持仓 772.16K $60.08M 21.75% 持有
FEDERATED HERMES, INC. 763.92K $59.44M 0.10% 增持
Holocene Advisors, LP 761.21K $59.23M 0.12% 减持
Commodore Capital LP 历史持仓 750.00K $58.36M 3.88% 持有
Goldman Sachs Group 740.31K $57.60M 0.02% 增持
UBS Group AG 737.03K $57.35M 0.03% 增持
FRONTIER CAPITAL MANAGEMENT CO LLC 历史持仓 635.96K $49.48M 0.53% 增持

Q3 2025 — 25 家基金

基金股数金额组合权重变化
BAKER BROS. ADVISORS LP 历史持仓 6.65M $376.47M 2.80% 持有
Avoro Capital Advisors LLC 历史持仓 6.35M $359.41M 5.33% 减持
Fidelity Management & Research (FMR) 5.88M $332.79M 0.02% 增持
BVF INC/IL 历史持仓 5.50M $311.45M 12.62% 持有
Vanguard Group 5.42M $306.87M 0.01% 减持
WELLINGTON MANAGEMENT GROUP LLP 5.20M $294.08M 0.06% 减持
Wellington Management Group 5.20M $294.08M 0.05% 减持
PRICE T ROWE ASSOCIATES INC /MD/ 5.10M $288.51M 0.03% 减持
Atlas Venture Life Science Advisors, LLC 历史持仓 4.90M $277.14M 36.82% 持有
BlackRock Inc 4.37M $247.08M 0.01% 增持
Siren, L.L.C. 历史持仓 3.43M $194.03M 7.59% 持有
STATE STREET CORP 2.02M $114.30M 0.00% 增持
Geode Capital Management 1.28M $72.28M 0.01% 增持
Capital Research Global Investors 1.26M $71.44M 0.01% 持有
Capital Research Global Investors 1.26M $71.44M 0.01% 持有
JENNISON ASSOCIATES LLC 1.03M $58.17M 0.03% 增持
DRIEHAUS CAPITAL MANAGEMENT LLC 历史持仓 939.09K $53.15M 0.38% 增持
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME 863.76K $48.89M 0.01% 增持
Holocene Advisors, LP 840.33K $47.56M 0.11% 新进
Merck & Co., Inc. 历史持仓 772.16K $43.70M 19.17% 持有
Commodore Capital LP 历史持仓 750.00K $42.45M 2.07% 持有
DIMENSIONAL FUND ADVISORS LP 731.42K $41.41M 0.01% 增持
Goldman Sachs Group 711.44K $40.27M 0.02% 增持
UBS Group AG 648.72K $36.72M 0.02% 增持
EVENTIDE ASSET MANAGEMENT, LLC 历史持仓 644.59K $36.48M 0.60% 增持

Q2 2025 — 25 家基金

基金股数金额组合权重变化
PRICE T ROWE ASSOCIATES INC /MD/ 6.86M $299.34M 0.03% 增持
BAKER BROS. ADVISORS LP 历史持仓 6.65M $290.27M 2.82% 增持
Avoro Capital Advisors LLC 历史持仓 6.56M $286.08M 5.01% 增持
Vanguard Group 5.62M $245.25M 0.00% 增持
BVF INC/IL 历史持仓 5.50M $240.14M 8.58% 增持
Fidelity Management & Research (FMR) 5.43M $237.05M 0.01% 增持
WELLINGTON MANAGEMENT GROUP LLP 5.37M $234.44M 0.05% 减持
Wellington Management Group 5.37M $234.44M 0.04% 减持
Atlas Venture Life Science Advisors, LLC 历史持仓 4.90M $213.68M 32.26% 持有
BlackRock Inc 4.15M $181.03M 0.01% 减持
Siren, L.L.C. 历史持仓 3.43M $149.60M 7.74% 增持
STATE STREET CORP 1.55M $67.84M 0.00% 减持
Capital Research Global Investors 1.26M $55.08M 0.01% 增持
Capital Research Global Investors 1.26M $55.08M 0.01% 增持
Geode Capital Management 1.19M $52.08M 0.00% 增持
DRIEHAUS CAPITAL MANAGEMENT LLC 历史持仓 933.89K $40.75M 0.33% 减持
JENNISON ASSOCIATES LLC 825.02K $36.00M 0.02% 增持
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME 818.93K $35.74M 0.01% 减持
Redmile Group, LLC 803.29K $35.06M 3.73% 减持
Merck & Co., Inc. 历史持仓 772.16K $33.70M 15.63% 持有
Commodore Capital LP 历史持仓 750.00K $32.73M 2.31% 新进
DEERFIELD MANAGEMENT COMPANY, L.P. 653.00K $28.50M 0.56% 增持
DIMENSIONAL FUND ADVISORS LP 563.37K $24.59M 0.01% 增持
EVENTIDE ASSET MANAGEMENT, LLC 历史持仓 562.99K $24.57M 0.43% 增持
UBS Group AG 557.73K $24.34M 0.01% 减持

查看全部 477 家持有基金 →

新建仓(Q2 2026)

完全清仓(较上季)

基金持仓历史 — 各季度股数(前 20 只基金)

基金Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Fidelity Management & Research (FMR) 12.57M 12.35M 11.70M 8.93M 5.88M 5.43M 4.41M 4.83M 5.11M 4.83M 4.36M 534.60K 870.55K 838.21K 667.35K 846.05K 325.69K 346.78K 1.92M 2.35M
BlackRock Inc 5.83M 5.54M 5.06M 5.00M 4.37M 4.15M 4.28M 4.36M 4.21M — — — — — — — — — — —
VANGUARD CAPITAL MANAGEMENT LLC 3.04M 2.93M 2.88M — — — — — — — — — — — — — — — — —
VANGUARD PORTFOLIO MANAGEMENT LLC 2.98M 2.99M 2.87M — — — — — — — — — — — — — — — — —
Atlas Venture Life Science Advisors, LLC 2.85M 2.85M 4.58M 4.66M 4.90M 4.90M 4.90M 4.90M 4.90M 5.35M 5.38M 5.86M 5.86M — — — — — — —
Siren, L.L.C. 2.78M 2.94M 3.19M 3.29M 3.43M 3.43M 3.24M 2.97M 2.97M — — — — — — — — — — —
STATE STREET CORP 2.58M — 2.39M 2.21M 2.02M 1.55M 1.76M 1.69M 1.73M 1.91M 2.67M 1.89M 1.99M — — — — — — —
Geode Capital Management 1.91M 1.82M 1.65M 1.42M 1.28M 1.19M 1.13M 1.11M 1.05M 1.05M 965.70K 880.51K 834.23K 801.28K 780.83K 747.07K 701.22K 675.85K 623.77K 620.04K
Capital Research Global Investors 1.13M 1.39M 1.67M 1.56M 1.26M 1.26M 365.19K — — — — — — — — — — — — —
UBS Group AG 1.03M 1.01M 1.02M 737.03K 648.72K 557.73K 593.61K 469.84K 217.62K 210.30K 296.68K 300.46K 162.76K 240.72K 185.29K 202.76K 49.69K 111.47K 136.09K 69.12K
Merck & Co., Inc. 772.16K 772.16K 772.16K 772.16K 772.16K 772.16K 772.16K 772.16K — — — — — — — — — — — —
FEDERATED HERMES, INC. 747.43K 749.40K 536.68K 763.92K 558.70K — — 32 6.73K 6.73K 6.77K — — — — — — — — —
DIMENSIONAL FUND ADVISORS LP 693.29K 745.15K 592.88K 624.03K 731.42K 563.37K 395.47K 433.75K 472.63K 402.38K 349.21K 533.72K 655.23K — — — — — — —
Franklin Resources 552.28K 515.05K 361.77K 354.57K 31.66K 33.65K 32.83K 38.37K 29.44K 21.79K — — — — — — — — — —
VANGUARD FIDUCIARY TRUST CO 503.09K 449.73K 427.38K — — — — — — — — — — — — — — — — —
EVENTIDE ASSET MANAGEMENT, LLC 490.61K 504.21K 626.92K 626.43K 644.59K 562.99K 525.14K 455.73K 507.90K 462.10K 19.77K — — — — — — — — —
Clearbridge Investments, LLC 396.83K 347.22K — — — — — — — — — — — — — — — — — —
BNP PARIBAS FINANCIAL MARKETS 382.80K 375.87K 285.87K 8.80K 10.65K 4.98K 3.42K 9.84K — — — — — — — — — — — —
Morgan Stanley 359.19K 194.84K 212.70K 274.02K 377.80K 237.60K 172.08K 239.76K 488.08K 631.74K 547.14K 441.28K 339.33K 405.90K 326.32K 237.80K 172.75K 334.15K 185.48K 82.12K
Fisher Asset Management, LLC 323.22K 12.73K — — — — — — — — — — — — — — — — — —

下载持有人名单 (CSV)

常见问题

Which funds hold KYMR?

As of 2026-Q2, 294 institutional funds reported holding KYMR (KYMERA THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $11.73B.

How many shares of KYMR do institutions own?

13F filers reported 109.68M shares of KYMR, worth $11.73B in aggregate at the end of 2026-Q2.

Is institutional ownership of KYMR rising or falling?

Share counts moved -0.1% versus the prior quarter — distribution.

Who are the top institutional holders of KYMR?

The largest 13F holders are Fidelity Management & Research (FMR), BAKER BROS. ADVISORS LP, Avoro Capital Advisors LLC, PRICE T ROWE ASSOCIATES INC /MD/, T. Rowe Price Investment Management, Inc.; the top 25 are ranked at the top of this page.

Who are the major shareholders of KYMERA THERAPEUTICS INC?

The major shareholders of KYMERA THERAPEUTICS INC (KYMR) by reported 13F value are Fidelity Management & Research (FMR), BAKER BROS. ADVISORS LP, Avoro Capital Advisors LLC, PRICE T ROWE ASSOCIATES INC /MD/, T. Rowe Price Investment Management, Inc., among 477 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

将本股票嵌入你的网站

复制下面的代码,即可在你的博客或论坛上展示「哪些传奇投资人持有 KYMR」的实时名单——免费、自动更新、回链 HoldingsHub。

<iframe src="https://holdingshub.top/stocks/KYMR/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

预览可嵌入组件 →